Published Date: 31-Oct-2019
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report North America Hip Replacement Implants Market, published by KBV Research, the North America Hip Replacement Implants Market would witness market growth of 4.4% CAGR during the forecast period (2019-2025).
The USA market dominated the North America Hip Replacement Implants Market by Country in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $2,178.9 million by 2025, growing at a CAGR of 3.9 % during the forecast period. The Canada market is expected to witness a CAGR of 4.7% during (2019 - 2025). Additionally, The Mexico market is expected to witness a CAGR of 6.7% during (2019 - 2025).
The Total Hip market registered the largest market share in the USA Hip Replacement Implants Market by Product in 2018, and is predicted to achieve a market value of $724.2 million by 2025. The Partial Femoral Head market is forecasted to witness a growth of 4.8% CAGR during (2019 - 2025).
The Hospitals & Surgery Centers market contributed the highest share to the revenue of North America Hip Replacement Implants Market by End Use in 2018, and would grow at a growth of 4% CAGR during the forecast period. The Orthopedic Clinics market is anticipated to experience a CAGR of 5% during (2019 - 2025).
The report highlights the adoption of Hip Replacement Implants in North America. Based on Application, the market is segmented into Metal-on-Metal, Metal-on-Polyethylene, Ceramic-on-Polyethylene, Ceramic-on-Metal and Ceramic-on-Ceramic. Based on Product, the market is segmented into Total Hip, Partial Femoral Head, Hip Resurfacing and Revision Hip. Based on End Use, the market is segmented into Orthopedic Clinics, Hospitals & Surgery Centers and Other End Use. The report also covers geographical segmentation of Hip Replacement Implants market. The countries included in the report are USA, Canada, Mexico and Rest of North America.
Key market participants profiled in this report includes Zimmer Biomet Holdings, Inc., Stryker Corporation, MicroPort Scientific Corporation, Smith & Nephew PLC, ConMed Corporation, B. Braun Melsungen AG, Exactech, Inc., Corin Group PLC, Colfax Corporation (DJO Global, Inc.) and Johnson & Johnson.
By End Use
Unique Offerings from KBV Research